First Personal Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$466 Buy
+1
New +$480 ﹤0.01% 403
2023
Q2
Sell
-94
Closed -$29.6K 409
2023
Q1
$29.6K Sell
94
-16
-15% -$4.8K 0.01% 252
2022
Q4
$31.8K Sell
110
-14
-11% -$4.27K 0.01% 252
2022
Q3
$36K Buy
+124
New +$35.7K 0.01% 228
2020
Q1
Sell
-12
Closed -$3K 527
2019
Q4
$3K Sell
12
-152
-93% -$30.8K ﹤0.01% 342
2019
Q3
$28K Buy
164
+10
+6% +$1.77K 0.01% 299
2019
Q2
$28K Hold
154
0.01% 365
2019
Q1
$28K Hold
154
0.01% 354
2018
Q4
$26K Buy
154
+18
+13% +$3.12K 0.01% 342
2018
Q3
$26K Buy
136
+45
+49% +$8.01K 0.01% 377
2018
Q2
$15K Sell
91
-64
-41% -$9.92K 0.01% 439
2018
Q1
$25K Buy
155
+17
+12% +$2.78K 0.01% 586
2017
Q4
$21K Buy
138
+128
+1,280% +$19K ﹤0.01% 641
2017
Q3
$2K Hold
10
﹤0.01% 817
2017
Q2
$1K Buy
+10
New +$1.2K ﹤0.01% 850
2016
Q4
Sell
-11
Closed -$1K 945
2016
Q3
$1K Hold
11
﹤0.01% 787
2016
Q2
$1K Buy
+11
New +$950 ﹤0.01% 799

Other funds holding VRTX

First Personal Financial Services's VRTX Position: Q3 2024 in Review

First Personal Financial Services opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2024: 1 share worth $466. The stake represents ﹤0.01% of the portfolio and ranks #403 among its holdings. This is a return to the name: First Personal Financial Services previously reported a position in VRTX as recently as Q1 2023.

First Personal Financial Services first reported a position in VRTX in Q2 2016 and has held it in 17 quarters since. The position peaked at $36K in Q3 2022. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • First Personal Financial Services held 1 share of Vertex Pharmaceuticals worth $466 as of Q3 2024.
  • Vertex Pharmaceuticals was a new First Personal Financial Services position in Q3 2024.
  • Vertex Pharmaceuticals made up ﹤0.01% of First Personal Financial Services's portfolio in Q3 2024, its #403 holding.
  • First Personal Financial Services first reported a position in Vertex Pharmaceuticals in Q2 2016 and has held it in 17 quarters since.
  • First Personal Financial Services's Vertex Pharmaceuticals position peaked at $36K in Q3 2022.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on First Personal Financial Services's 13F filing for Q3 2024, filed 1 Nov 2024.